Liberty Street Advisors’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Liberty Street Advisors’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$217K	Buy	+19,960	New	+$196K	3.47%	17

Other funds holding SZYM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Liberty Street Advisors's SZYM Position: Q4 2013 in Review

Liberty Street Advisors opened a new position in SOLAZYME INC COM STK (DE) (SZYM) in Q4 2013: 19,960 shares worth $217K. The stake represents 3.47% of the portfolio and ranks #17 among its holdings.

105 funds tracked by Wall St. Rank hold SZYM as of Q4 2013.

Liberty Street Advisors held 19,960 shares of SOLAZYME INC COM STK (DE) worth $217K as of Q4 2013.
SOLAZYME INC COM STK (DE) was a new Liberty Street Advisors position in Q4 2013.
SOLAZYME INC COM STK (DE) made up 3.47% of Liberty Street Advisors's portfolio in Q4 2013, its #17 holding.
105 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2013.

Based on Liberty Street Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.